VOR BIOPHARMA INC (VOR:NASDAQ)
$15.48 -0.12 (-0.7692%)
Analysed VOR BIOPHARMA INC (VOR:NASDAQ) News Sources
Vor Biopharma (VOR) Upgraded to Buy: Here's Why
02-04-2026
yahoo.com
Wall Street Analysts Predict a 107.82% Upside in Vor Biopharma (VOR): Here's What You Should Know
02-04-2026
yahoo.com
Vor Bio Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
01-04-2026
yahoo.com
Vor Bio Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Corporate Update
30-03-2026
yahoo.com
Vor Bio Doses First Patient in Global Phase 3 UPSTREAM SjD Registrational Trial of Telitacicept in Primary Sjögren’s Disease
30-03-2026
yahoo.com
Vor Bio Announces $75 Million Private Placement with TCGX
27-03-2026
yahoo.com
Vor Bio Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
23-03-2026
yahoo.com
Vor Bio to Participate in the 46th Annual TD Cowen Health Care Conference
23-02-2026
yahoo.com
Vor Bio to Participate in the 44th Annual J.P. Morgan Healthcare Conference
06-01-2026
yahoo.com
Vor Bio Appoints RA Capital’s Andrew Levin, M.D., Ph.D., and Forbion’s Wouter Joustra to Board of Directors
23-12-2025
yahoo.com
What is the current price of VOR BIOPHARMA INC (VOR:NASDAQ)?
The current price of VOR BIOPHARMA INC (VOR:NASDAQ) is $15.48.
VOR BIOPHARMA INC (VOR:NASDAQ) absolute price change since previous trading day?
The absolute price change of VOR BIOPHARMA INC (VOR:NASDAQ) since the previous trading day is $-0.12.
VOR BIOPHARMA INC (VOR:NASDAQ) percentage price change since previous trading day?
The percentage price change of VOR BIOPHARMA INC (VOR:NASDAQ) since the previous trading day is -0.7692%.
What is the most recent average sentiment score for VOR BIOPHARMA INC (VOR:NASDAQ)?
The most recent average sentiment score for VOR BIOPHARMA INC (VOR:NASDAQ) is 74 out of 100.
What is the most recent average sentiment for VOR BIOPHARMA INC (VOR:NASDAQ)?
The most recent sentiment for VOR BIOPHARMA INC (VOR:NASDAQ) is .
SEC-8K** Filing Available For VOR BIOPHARMA INC (VOR:NASDAQ)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.